International Hyperhidrosis Society

Botulinum Toxin A and Treatment of Hyperhidrosis

Botulinum toxin A injection therapy has been used successfully to reduce excessive sweating in all of the body areas affected in primary hyperhidrosis: axillary, palmoplantar, and facial/gustatory. Characterized as a “minimally invasive treatment option” compared to local surgery and endoscopic thoracic sympathectomy, the use of botulinum toxin A has become an important treatment option for patients not responding to more-conservative therapies.

OnabotulinumtoxinA (brand name Botox) has been approved for use in hyperhidrosis in Canada, the U.K. and other countries in Europe and South America (more than 25 countries total). In 2004, the US Food and Drug Administration (FDA) approved onabotulinumtoxinA for the treatment of severe primary axillary hyperhidrosis in patients unable to obtain relief using antiperspirants.


Pin It

Sign Up for Our News Blog

Page 1 of 4

  1. Get inside intel, research results, event invites!
  2. First Name*
    Please type your first name.
  3. Last Name
    Please type your last name.
  4. Email*
    Invalid email address.
  5. Year of Birth*
    Invalid Input
  1. Gender*
    Please indicate your gender.
  2. Tell us about you.*

    Please tell us who you are in the hyperhidrosis community.
  1. Country*
    Please select your country where you live.
  2. Postal or Zip Code*
    Invalid Input
  1. Where do you sweat excessively?*

    Please tell us where you sweat so we can help you and others.
  2. Fight SPAM*
    Invalid Input